Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -5.88 | 20.84 |
| PEG Ratio (TTM) | -2.41 | 2.52 |
| P/S Ratio (TTM) | 0.51 | 1.49 |
| P/B Ratio (TTM) | 1.07 | 7.00 |
| P/FCF Ratio (TTM) | 14.08 | 14.69 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.90 |
| Price to 5YR AVG FCF Ratio | N/A | 17.44 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -6.25% | 5.27% |
| ROE (TTM) | -17.57% | 42.57% |
| Net Profit Margin (TTM) | -8.53% | 5.06% |
| ROIC 5YR AVG | N/A | 15.60% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -132.91% | -167.88% | N/A |
| Revenue | 4.05% | 25.88% | N/A |
| Net Income | -141.74% | -170.46% | N/A |
| Cash Flow | 15.42% | 37.48% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.09 | 1.58 |
| Quick Ratio (TTM) | 1.08 | 0.87 |
| D/E Ratio (TTM) | 1.47 | 1.52 |
| Interest Coverage (TTM) | -0.31 | 18.79 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.00 | 3.68 |
| LTL to 5YR AVG FCF | N/A | 7.02 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.61% |